Skip to main content
. 2016 Apr 19;17(4):593. doi: 10.3390/ijms17040593

Figure 3.

Figure 3

Mechanisms of the sEGFR isoform anti-tumoral action. The sEGFR can avoid the ligand-dependent EGFR activation sequestering the ligand (purple pentagon) (A) or directly binding the EGFR ECD (B).